Patents by Inventor Robert R. Chauvette

Robert R. Chauvette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4334065
    Abstract: 7.alpha.-(Dimethylamidino)-3-cephem ester 1.alpha.-oxides represented by the formula ##STR1## wherein R is hydrogen or acetoxy and R.sub.1 is a carboxy protecting group, are prepared via DBU epimerization of the corresponding 7.beta.-isomer. When R is hydrogen the intermediates are useful in the preparation of the 7.beta.-acylamino-7.alpha.-methoxy-1-oxa-.beta.-lactam antibiotics, and when R is acetoxy the compounds are intermediates to 7.beta.-acylamino-7.alpha.-methoxy-3-exomethylenecepham compounds.
    Type: Grant
    Filed: November 24, 1980
    Date of Patent: June 8, 1982
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4316842
    Abstract: 6-Epi penicillin .alpha.-sulfoxides represented by the formula ##STR1## wherein R is a carboxy protecting group, are useful for preparing antibiotic compounds and are prepared via epimerization with an alkali metal acetate of corresponding 6.beta.-epimer.
    Type: Grant
    Filed: November 24, 1980
    Date of Patent: February 23, 1982
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4281117
    Abstract: 7-Amino-3-hydroxy-3-cephem esters react with a chlorinating agent, e.g. phosgene, thionyl chloride and preferably PCl.sub.3 -DMF to provide 7.beta.-[(dimethylaminomethylene)amino]-3-chloro-3-cephem esters which on reaction with a carboxylic acid, a percarboxylic acid, or a phenol, having a pH in water of about 2-5, afford 7.beta.-formamido-3-chloro-3-cephem esters, and corresponding 2-cephem esters. Percarboxylic acids provide 7.beta.-formamido-3-chloro-3-cephem ester 1-oxides. The 7-formamido derivatives provide the 7-amino-3-chloro-3-cephem ester on acid hydrolysis. The 7-amino-3-chloro esters are useful for preparing antibiotics.
    Type: Grant
    Filed: September 4, 1980
    Date of Patent: July 28, 1981
    Assignee: Eli Lilly and Company
    Inventors: Pamela A. Chauvette, Robert R. Chauvette
  • Patent number: 4281116
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: July 2, 1980
    Date of Patent: July 28, 1981
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4260745
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: October 12, 1979
    Date of Patent: April 7, 1981
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4252950
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: October 12, 1979
    Date of Patent: February 24, 1981
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4208515
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: April 5, 1977
    Date of Patent: June 17, 1980
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4064343
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: February 9, 1976
    Date of Patent: December 20, 1977
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4060688
    Abstract: 3-Exomethylenecepham and 3-hydroxy-3-cephem sulfoxides represented by the formulas ##STR1## wherein R is an acyl group derived from a carboxylic acid and R.sub.1 is a carboxylic acid protecting group, are useful intermediates in the synthesis of 3-alkoxy-3-cephem, 3-chloro-3-cephem and 3-methyl-3-cephem antibiotic compounds.
    Type: Grant
    Filed: June 6, 1975
    Date of Patent: November 29, 1977
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 4008228
    Abstract: 7-Acylamino-3-methyl-3-cephem-4-carboxylic acids and esters are prepared via the reductive cleavage of a 3-thio substituted 2-cephem-4-carboxylic acid or ester with hydrogen and Raney nickel or zinc in formic acid and DMF to provide reduction product mixtures of the corresponding 7-substituted 3-methyl-2-cephem-4-acid or ester (I) and 3-exomethylenecepham-4-acid or ester (II). Reduction product mixtures are separable via chromatography and individual I and II are isomerized to 3-methyl-3-cephem antibiotics.
    Type: Grant
    Filed: July 14, 1975
    Date of Patent: February 15, 1977
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 3992377
    Abstract: 7-Acylamido-3-cephem-4-carboxylic acid antibiotics directly substituted in the 3-position of the cephem ring system with a sulfur atom bonded to a 5- or 6-membered heterocyclic ring, a lower alkyl group, or a phenyl or substituted phenyl group are prepared with the corresponding 3-halo-3-cephem esters. For example, p-nitrobenzyl 7-[2-(2-thienyl)acetamido]-3-chloro-3-cephem-4-carboxylate reacts with 1-methyl-1H-tetrazol-5-ylthiol to provide p-nitrobenzyl 7-[2-(2-thienyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thio]-3-cephem-4- carboxylate. The p-nitrobenzyl ester group is removed by catalytic hydrogenolysis to provide the antibiotic carboxylic acid compound. Alternatively, the antibiotics are prepared by reacting a 3-alkylsulfonyloxy, or 3-arylsulfonyloxy-3-cephem, for example, 3-methanesulfonyloxy-3-cephem, or a 3-p-toluenesulfonyloxy-3-cephem with the heterocyclic thiol, the phenyl or substituted phenylthiol, or with the lower alkylthiol.
    Type: Grant
    Filed: December 13, 1974
    Date of Patent: November 16, 1976
    Assignee: Eli Lilly and Company
    Inventors: Robert R. Chauvette, Gary A. Koppel
  • Patent number: 3962227
    Abstract: 7-Acylamido- and 7-amino-3-halo-3-cephem-4-carboxylic acids, esters and pharmaceutically-acceptable salts and esters thereof are new cephalosporin compounds provided by the reaction of a 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid ester or a 7-amino-3-hydroxy-3-cephem-4-carboxylic acid ester with an iodinating, fluorinating, chlorinating, or brominating reagent. For example, 7-amino-3-chloro-3-cephem-4-carboxylic acid and 7-phenoxyacetamido-3-chloro-3-cephem-4-carboxylic acid are provided. The 7-acylamido-3-halo cephalosporin acids and pharmaceutically acceptable salts and esters provided are valuable antibiotic compounds having desirable therapeutic properties.
    Type: Grant
    Filed: April 1, 1974
    Date of Patent: June 8, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette
  • Patent number: 3932393
    Abstract: 3-Methylenecepham-4-carboxylic acids and esters of the Formula I and 3-methyl-.DELTA..sup.3 -cephem-4-carboxylic acids and esters of the Formula II ##SPC1##where R is hydrogen or an organic acyl group and R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl a carboxylic acid protecting group or a pharmaceutically acceptable cation are prepared via the reductive displacement of a 3-substituted methyl cephalosporin of the Formula III ##SPC2##where R.sub.2 is an organic residue such that --SR.sub.2 constitutes a reductively displaceable moiety, and R and R.sub.1 have the same meanings as defined in Formulae I and II, reductive displacement being accomplished by catalytic hydrogenation or chemical reduction. The 3-methylene cepham compounds are isomerized in dimethylacetamide in the presence of a tertiary alkyl amine to provide 3-methyl-7-acylamido-.DELTA..sup.3 -cephem-4-carboxylic acids and esters.
    Type: Grant
    Filed: February 25, 1971
    Date of Patent: January 13, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert R. Chauvette